GL1X · GenesisL1 explorer

MolNFT v2 · #6423 · protein

Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo anti-resorptive activity

MolNFT v2 record #6423 on GenesisL1: PDB 1FBZ, “Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo anti-resorptive…”. Protein, 208 residues in 2 chains. 3D structure, sequence…

PDB
1FBZ
Type
protein
Length
208 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.